Hongwei Jin
38 Xueyuan Road
Beijing, 100191, China
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Structure-Based Discovery of a New LpxH-Targeted Chemotype with Activity against Klebsiella pneumoniae.
Journal: Journal of medicinal chemistry
Published: March 05, 2026
Editor's Note: Tumor Imaging and Interferon-γ-Inducible Protein-10 Gene Transfer Using a Highly Efficient Transferrin-Conjugated Liposome System in Mice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 29, 2025
Neferine inhibits Zika virus replication by targeting viral protease.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 04, 2025
Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agents.
Journal: RSC medicinal chemistry
Published: April 03, 2025
Design, synthesis, anticancer activity evaluation and molecular dynamics study of pyrazine N-oxide-based SHP2 allosteric inhibitors.
Journal: European journal of medicinal chemistry
Published: January 29, 2025
Geometry-based BERT: An experimentally validated deep learning model for molecular property prediction in drug discovery.
Journal: Journal of pharmaceutical analysis
Published: December 20, 2024
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.
Journal: Molecular cancer
Published: December 03, 2024
Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation.
Journal: Chemistry & biodiversity
Published: November 18, 2024
Machine Learning-Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent.
Journal: Chemical biology & drug design
Published: November 07, 2024
CD1B Expression in Triple-Negative Breast Cancer: Its Implications for Prognosis and Immunotherapy Outcomes.
Journal: Current gene therapy
Published: October 15, 2024
Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection.
Journal: European journal of medicinal chemistry
Published: August 24, 2024
Last Updated: 09/26/2026